Document is current
Any future updates will be listed below
-
Authors
Bizjak, Daniel A. https://orcid.org/0000-0003-4075-0204
Nussbaumer, Dorle
Winkert, Kay https://orcid.org/0000-0002-3460-2320
Treff, Gunnar https://orcid.org/0000-0001-5388-4282
Takabajashi, Kensuke
Mentz, Lennart https://orcid.org/0000-0001-7017-2746
Schober, Franziska
Buhl, Jasmine-Lèonike
John, Lucas https://orcid.org/0000-0001-7602-2239
Dreyhaupt, Jens https://orcid.org/0000-0001-8057-161X
Steeb, Luise
Harps, Lukas C.
Parr, Maria K. https://orcid.org/0000-0001-7407-8300
Diel, Patrick https://orcid.org/0000-0002-8512-2001
Zügel, Martina
Steinacker, Jürgen M. https://orcid.org/0000-0001-8901-9450
-
Clinical Trials BETA
Clinical trials referenced in this document:
drks00010574 at German Clinical Trials RegisterDocuments that mention this clinical trial
Acute Effects of Single Versus Combined Inhaled β2-Agonists Salbutamol and Formoterol on Time Trial Performance, Lung Function, Metabolic and Endocrine Variables
https://doi.org/10.1186/s40798-023-00630-3
-
Funding
Funding for this research was provided by:
World Anti-Doping Agency (15C13MZ)
Universitätsklinikum Ulm
- License Information
-
More Information
Article History
Received: 12 March 2023
Accepted: 17 August 2023
First Online: 28 August 2023
Declarations
:
: The study was approved by the ethics committee of Ulm University (number 64/19) and was performed in accordance with the Declaration of Helsinki. All participants gave written informed consent to participate in this study.
: Not applicable.
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. No professional interests, personal relationships or personal beliefs had any influence on the presentation of the study data.
